In 2025, the European Commission proposed a new law aimed at strengthening the supply of critical medicines within the European Union. The goal is to ensure the health security of EU citizens by guaranteeing the availability of essential medicines and preventing shortages that could jeopardize public health. This regulatory framework is designed to make supply chains more resilient, encourage local production, and enhance transparency in distribution.

This initiative marks an important step toward promoting equitable and safe access to healthcare, but it also raises a key question: how can companies and organizations demonstrate their tangible contribution to ensuring access to healthcare, particularly in the most vulnerable regions?

At Regg3, ensuring access to healthcare is more than just a strategic goal—it’s a measurable commitment. Through its Health impact area, Regg3 uses two key indicators to assess the availability and affordability of healthcare services:

• UHC-SCI (Universal Health Coverage Service Coverage Index), which measures the extent of coverage for essential healthcare services.
• ICHS (Incidence of Catastrophic Health Spending), which analyzes the percentage of the population forced to bear healthcare costs so high they jeopardize their economic well-being.

By using these indicators, Regg3 can pinpoint existing gaps between the ideal threshold (as defined by international standards) and the realities on the ground.

Regg3’s approach was recently applied to assess the impact of an organization operating in a Gulf country, with the aim of optimizing its Corporate Social Responsibility (CSR) strategy in the healthcare sector. The analysis identified the areas of greatest need, mapped the organization’s contributions against territorial gaps, and provided a data-driven strategy to maximize the effectiveness of its social investments.

One key insight emerged from the analysis: although the country had relatively high healthcare coverage (UHC-SCI above the global threshold of 80%), the percentage of the population affected by catastrophic health spending (ICHS) exceeded the recommended limit of 10%, reaching 15%.
This information enabled the organization to design targeted interventions to reduce the financial burden on the most vulnerable populations. Actions included:

• Supporting subsidized health insurance programs for disadvantaged groups
• Investing in free or low-cost healthcare services through public-private partnerships
• Funding telemedicine solutions to improve accessibility and reduce transportation and consultation costs

Regg3 tracked the evolution of the organization’s impact, monitoring how these initiatives progressively reduced the identified gap. Once the organization’s efforts resulted in a 2% reduction in ICHS, an official impact certification was issued, acknowledging the value created for the local community.

In a regulatory landscape that rewards companies for concrete commitments to sustainability and healthcare resilience, Regg3’s certification offers a strategic advantage. Not only does it provide verifiable data to include in ESG reports, but it also enhances credibility with investors, institutions, and local stakeholders.

With this methodology, companies can:

• Demonstrate their real contribution to improving healthcare access, aligned with international standards
• Strengthen relationships with local institutions by showcasing transparent, concrete action
• Access funding and partnerships more easily, thanks to the credibility provided by official certification

Promoting access to healthcare is not just a regulatory duty—it’s a competitive advantage.